South America Poultry Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Broiler, Layer, and Breeder), Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Others), Dosage Form (Liquid vaccines, Freeze-Dried Vaccines, and Dust/Powdered Vaccines), Disease [Newcastle Disease, Avian Influenza, Marek's Disease, Infectious Bronchitis (IB), Infectious Bursal Disease (IBD), Salmonellosis, and Others], Route of Administration [Drinking Water (D/W) and Spray, Intramuscular (I/M), Subcutaneous (S/C), and Others], and End User (Poultry Farms and Hatcheries, Veterinary Hospitals, and Poultry Vaccination Centers and Clinics)

TIPRE00023752 | Pages: 105 | Pharmaceuticals | Jul 2022 | Type: Regional | Status: Published

The South America poultry vaccines market is expected to reach US$ 139.54 million by 2028 from US$ 101.99 million in 2021. The market is estimated to grow at a CAGR of 4.6% from 2021 to 2028.

 

The South America poultry vaccines market is characterized by various small and big companies.The market players are adopting the strategies such as new product launches, regional expansion, and technological advancements to increase their market share. Market players are investing in R&D to develop advanced technologies and gain more revenue share. For instance, in July 2019, CEVA SANTÉ ANIMALE Company and IDT Biologika GmbH announced their successful completion of the acquisition of IDT's veterinary biopharmaceutical as well as R&D activities by CEVA SANTÉ ANIMALE. Similarly, in 2020, Merck Poultry Vaccines signed a partnership agreement with Automazioni VX, Inc. (US). The partnership aimed to introduce Innoject Pro, a newly designed subcutaneous chick vaccination technology. The technology will be combined with Merck Animal Health's Innovax range of vaccines, which is used to protect against infectious poultry diseases. Further, in January 2020, Boehringer Ingelheim's and Poultry Vaccines business launched a vaccine named VAXXITEK HVT+IBD+ND to protect poultry from three diseases and provide a strong immune foundation and optimized protection against Marek's disease, infectious bursal disease (classic and variant types) and Newcastle disease. The market players are also likely to enter strategic ventures to bring in new products. For instance, in June 2018, MSD Animal Health, a Merck & Co., Inc. subsidiary, entered into a partnership agreement with Vinovo B.V. This synergistic partnership combined a broad vaccine portfolio with a novel delivery system to protect against highly infectious poultry diseases efficiently and effectively. The South America poultry vaccines market is expected to grow at a good CAGR during the forecast period.

 

South America Poultry Vaccines Revenue and Forecast to 2028 (US$ Million)

South America Poultry Vaccines Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :

  

 

  

South America Poultry Vaccines Market Segmentation

 

The South America poultry vaccines market is segmented based on type, technology, dosage form, disease, route of administration, end user, and country. Based on type, the market is segmented into broiler, layer, and breeder. The breeder segment dominated the South America poultry vaccines market in 2020. In terms of technology, the market is segmented into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment dominated the South America poultry vaccines market in 2020. Based on dosage form, the market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment dominated the South America poultry vaccines market in 2020. Based on disease, the market is segmented into Newcastle disease, avian influenza, Marek's disease, infectious bronchitis (IB), infectious bursal disease (IBD), salmonellosis, and others. The Newcastle disease dominated the South America poultry vaccines market in 2020. Based on route of administration, the market is segmented into drinking water (d/w) and spray, intramuscular (i/m), subcutaneous (s/c), and others. The drinking water (d/w) and spray segment dominated the South America poultry vaccines market in 2020. Based on end user, the market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatchery segment dominated the South America poultry vaccines market in 2020. Based on country, the South America poultry vaccines market is segmented into Brazil, Argentina, and the Rest of South America. Brazil dominated the South America poultry vaccines market in 2020.

             

Boehringer Ingelheim International GmbH, Zoitis Inc., Ceya Santae Animale, BIOVAC, PHIBRO ANIMAL HEALTH CORPORATION, Hester Biosciences Limited, Dechra Pharmaceutical Plc, Elanco, and Merck Animal Health are among the leading companies in South America poultry vaccines market.

1.          Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Poultry Vaccines Market – By Type

1.3.2        SAM Poultry Vaccines Market – By Technology

1.3.3        SAM Poultry Vaccines Market – By Dosage Form

1.3.4        SAM Poultry Vaccines Market – By Disease

1.3.5        SAM Poultry Vaccines Market – By Route of Administration

1.3.6        SAM Poultry Vaccines Market – By End User

1.3.7        SAM Poultry Vaccines Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Poultry Vaccines Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        South & Central America PEST Analysis

4.3         Experts Opinion

5.           SAM Poultry Vaccines Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Diseases in Poultry

5.1.2        Increasing Demand for Healthy Poultry Food

5.2         Market Restraints

5.2.1        Failure of Vaccines in Poultry Production

5.3         Market Opportunities

5.3.1        Rising Growth of Market in Untapped Economies

5.4         Future Trends

5.4.1        Key Business Strategies to Enhance Market Growth in Future

5.5         Impact Analysis

6.           Poultry Vaccines Market– SAM Analysis

6.1         SAM Poultry Vaccines Market Revenue Forecast and Analysis

6.1.1        Poultry Vaccines Market Revenue Forecast and Analysis

7.           SAM Poultry Vaccines Market Analysis – By Type

7.1         Overview

7.2         Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)

7.3         Broiler

7.3.1        Overview

7.3.2        Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Layer

7.4.1        Overview

7.4.2        Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Breeder

7.5.1        Overview

7.5.2        Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.           SAM Poultry Vaccines Market Analysis – By Technology

8.1         Overview

8.2         Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)

8.3         Live Attenuated Vaccines

8.3.1        Overview

8.3.2        Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Inactivated Vaccines

8.4.1        Overview

8.4.2        Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.5         Recombinant Vaccines

8.5.1        Overview

8.5.2        Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.           SAM Poultry Vaccines Market Analysis – By Dosage Form

9.1         Overview

9.2         Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)

9.3         Liquid Vaccines

9.3.1        Overview

9.3.2        Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Freeze-Dried Vaccines

9.4.1        Overview

9.4.2        Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Dust/Powdered Vaccines

9.5.1        Overview

9.5.2        Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.        SAM Poultry Vaccines Market Analysis – By Disease

10.1      Overview

10.2      Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)

10.3      Infectious Bronchitis

10.3.1     Overview

10.3.2     Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Avian Influenza

10.4.1     Overview

10.4.2     Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.5      Marek's Disease

10.5.1     Overview

10.5.2     Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.6      Infectious Bursal Disease

10.6.1     Overview

10.6.2     Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.7      Salmonellosis

10.7.1     Overview

10.7.2     Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.8      Newcastle Disease

10.8.1     Overview

10.8.2     Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

10.9      Others

10.9.1     Overview

10.9.2     Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.        SAM Poultry Vaccines Market Analysis – By Route of Administration

11.1      Overview

11.2      Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)

11.3      Drinking water (D/W) & Spray

11.3.1     Overview

11.3.2     Drinking water (D/W) & Spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.4      Intramuscular (I/M)

11.4.1     Overview

11.4.2     Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.5      Subcutaneous (S/C)

11.5.1     Overview

11.5.2     Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

11.6      Others

11.6.1     Overview

11.6.2     Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.        SAM Poultry Vaccines Market Analysis – By End User

12.1      Overview

12.2      Poultry Vaccines Market Share, by End User, 2021 and 2028, (%)

12.3      Veterinary Hospitals

12.3.1     Overview

12.3.2     Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.4      Poultry Vaccination Centers & Clinics

12.4.1     Overview

12.4.2     Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

12.5      Poultry Farms and Hatchery

12.5.1     Overview

12.5.2     Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.        SAM Poultry Vaccines Market – Country Analysis

13.1      South & Central America Poultry Vaccines Market Revenue and Forecasts To 2028

13.1.1     Overview

13.1.2     South & Central America: Poultry Vaccines Market, by Country, 2021 & 2028 (%)

13.1.2.1       Brazil: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.1       Brazil: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.2       Brazil Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.3       Brazil Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.4       Brazil Poultry Vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.5       Brazil Poultry Vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.6       Brazil Poultry Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

13.1.2.1.7       Brazil Poultry Vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2       Argentina: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.1       Argentina: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.2       Argentina Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.3       Argentina Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.4       Argentina Poultry Vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.5       Argentina Poultry Vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.6       Argentina Poultry Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

13.1.2.2.7       Argentina Poultry Vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3       Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.1       Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.2       Rest of South and Central America Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.3       Rest of South and Central America Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.4       Rest of South and Central America Poultry Vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.5       Rest of South and Central America Poultry Vaccines Market, by Disease– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.6       Rest of South and Central America Poultry Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

13.1.2.3.7       Rest of South and Central America Poultry Vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)

14.        Industry Landscape

14.1      Overview

14.2      Organic Developments

14.2.1     Overview

14.3      Inorganic Developments

14.3.1     Overview

15.        Company Profiles

15.1      Boehringer Ingelheim International GmbH

15.1.1     Key Facts

15.1.2     Business Description

15.1.3     Products and Services

15.1.4     Financial Overview

15.1.5     SWOT Analysis

15.1.6     Key Developments

15.2      Zoetis Inc.

15.2.1     Key Facts

15.2.2     Business Description

15.2.3     Products and Services

15.2.4     Financial Overview

15.2.5     SWOT Analysis

15.2.6     Key Developments

15.3      Ceva Santé Animale

15.3.1     Key Facts

15.3.2     Business Description

15.3.3     Products and Services

15.3.4     Financial Overview

15.3.5     SWOT Analysis

15.3.6     Key Developments

15.4      BIOVAC

15.4.1     Key Facts

15.4.2     Business Description

15.4.3     Products and Services

15.4.4     Financial Overview

15.4.5     SWOT Analysis

15.4.6     Key Developments

15.5      PHIBRO ANIMAL HEALTH CORPORATION

15.5.1     Key Facts

15.5.2     Business Description

15.5.3     Products and Services

15.5.4     Financial Overview

15.5.5     SWOT Analysis

15.5.6     Key Developments

15.6      Hester Biosciences Limited

15.6.1     Key Facts

15.6.2     Business Description

15.6.3     Products and Services

15.6.4     Financial Overview

15.6.5     SWOT Analysis

15.6.6     Key Developments

15.7      Dechra Pharmaceuticals PLC

15.7.1     Key Facts

15.7.2     Business Description

15.7.3     Products and Services

15.7.4     Financial Overview

15.7.5     SWOT Analysis

15.7.6     Key Developments

15.8      Elanco

15.8.1     Key Facts

15.8.2     Business Description

15.8.3     Products and Services

15.8.4     Financial Overview

15.8.5     SWOT Analysis

15.8.6     Key Developments

15.9      Merck Animal Health

15.9.1     Key Facts

15.9.2     Business Description

15.9.3     Products and Services

15.9.4     Financial Overview

15.9.5     SWOT Analysis

15.9.6     Key Developments

16.        Appendix

16.1      About the Insight Partners

16.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Brazil Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Brazil Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 3.             Brazil Poultry Vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Brazil Poultry Vaccines Market, by Disease – Revenue and Forecast to 2028 (US$ Million)

Table 5.             Brazil Poultry Vaccines Market, by Route of Administration – Revenue and Forecast to 2028 (US$ Million)

Table 6.             Brazil Poultry Vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Argentina Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Argentina Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Argentina Poultry Vaccines Market, by Dosage Form – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Argentina Poultry Vaccines Market, by Disease– Revenue and Forecast to 2028 (US$ Million)

Table 11.          Argentina Poultry Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 12.          Argentina Poultry Vaccines Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Rest of South and Central America Poultry Vaccines Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Rest of South and Central America Poultry Vaccines Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Rest of South and Central America Poultry Vaccines Market, by Dosage Form– Revenue and Forecast to 2028 (US$ Million)

Table 16.          Rest of South and Central America Poultry Vaccines Market, by Disease– Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of South and Central America Poultry Vaccines Market, by Route of Administration– Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of South and Central America Poultry Vaccines Market, by End User – Revenue and Forecast to 2028(US$ Million)

Table 19.          Organic Developments in the Poultry Vaccine Market

Table 20.          Inorganic Developments in the Poultry Vaccine Market

Table 21.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           SAM Poultry Vaccines Market Segmentation

Figure 2.           SAM Poultry Vaccines Market, By Country

Figure 3.           SAM Poultry Vaccines Market Overview

Figure 4.           Breeder Segment Held Largest Share of Type Segment in SAM Poultry Vaccines Market

Figure 5.           SAM is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           South & Central America: PEST Analysis

Figure 7.           SAM Experts Opinion

Figure 8.           SAM Poultry Vaccines Market: Impact Analysis of Drivers and Restraints

Figure 9.           SAM Poultry Vaccines Market– Revenue Forecast and Analysis – 2020- 2028

Figure 10.        SAM Poultry Vaccines Market Revenue Share, by Type (2021 and 2028)

Figure 11.        SAM Broiler: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        SAM Layer: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        SAM Breeder: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        SAM Poultry Vaccines Market Revenue Share, by Technology (2021 and 2028)

Figure 15.        SAM Live attenuated vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        SAM Inactivated Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        SAM Recombinant Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        SAM Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        SAM Poultry Vaccines Market Revenue Share, by Dosage Form (2021 and 2028)

Figure 20.        SAM Liquid Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        SAM Freeze-Dried Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        SAM Dust/Powdered Vaccines: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        SAM Poultry Vaccines Market Revenue Share, by Disease (2021 and 2028)

Figure 24.        SAM Infectious Bronchitis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        SAM Avian Influenza: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        SAM Marek’s Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        SAM Infectious Bursal Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        SAM Salmonellosis: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        SAM Newcastle Disease: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        SAM Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        SAM Poultry Vaccines Market Revenue Share, by Route of Administration (2021 and 2028)

Figure 32.        SAM Drinking water (D/W) & spray: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        SAM Intramuscular (I/M): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 34.        SAM Subcutaneous (S/C): Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        SAM Others: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        SAM Poultry Vaccines Market Share, by End User, 2021 and 2028 (%)

Figure 37.        SAM Veterinary Hospitals: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 38.        SAM Poultry Vaccination Centre: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 39.        SAM Poultry Farms and Hatchery: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 40.        South & Central America: Poultry Vaccines Market, by Key Country – Revenue (2021) (US$ Million)

Figure 41.        South & Central America: Poultry Vaccines Market, by Country, 2021 & 2028 (%)

Figure 42.        Brazil: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 43.        Argentina: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 44.        Rest of South and Central America: Poultry Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

1.Boehringer Ingelheim Intrnational GmbH.

2.Zoitis Inc.

3.Ceya Santae Animale.

4.BIOVAC.

5.PHIBRO ANIMAL HEALTH CORPORATION.

6.Hester Biosciences Limited.

7.Dechra Pharmaceutical Plc.

8. Elanco.

9.Merck Animal Health

 

 

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South America Poultry Vaccines market forecast.   
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in South America Poultry Vaccines market forecast, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South America market trends and outlook coupled with the factors driving the poultry vaccines market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000